Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Feb;86(2):154-225.
doi: 10.1016/j.jinf.2022.11.009. Epub 2022 Nov 17.

Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study

Alexander Rombauts  1 , Carmen Infante  2 , Mikel Del Álamo Martínez de Lagos  3 , Jorge Alba  4 , Adoración Valiente  5 , Carla Donado-Mazarrón  1 , Marta Carretero-Ledesma  6 , Regino Rodríguez-Álvarez  3 , Sonia Omatos  4 , Zaira R Palacios-Baena  5 , Gabriela Abelenda-Alonso  1 , María Del Mar Silva-Sánchez  6 , Ane Josune Goikoetxea-Agirre  3 , José A Oteo  4 , Jesús Rodríguez-Baño  7 , Elisa Cordero  8 , Carlota Gudiol  9 , Javier Sánchez-Céspedes  10 , Jordi Carratalà  9
Affiliations
Observational Study

Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study

Alexander Rombauts et al. J Infect. 2023 Feb.
No abstract available

Keywords: COVID-19; Long-COVID; Risk factors; SARS-CoV-2 RNAemia; Viral load.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None of the study authors have conflicts of interest to declare.

Figures

Fig 1
Fig. 1
Comparison between long-COVID manifestations in patients with and without SARS-CoV-2 RNAemia.
Fig 2
Fig. 2
Risk factors associated with worsened quality of life compared to one-year before hospitalization for COVID-19 (age-adjusted). ICU: intensive care unit; ARDS: acute respiratory distress syndrome; ACE: angiotensin-converting enzyme; WHO: Severity rating according to the WHO Clinical Progression Scale, ranged from 0 (not infected) to 10 (dead), doi: 10.1016/S1473-3099(20)30483-7.
See this image and copyright information in PMC

References

    1. Righi E., Mirandola M., Mazzaferri F., Dossi G., Razzaboni E., Zaffagnini A., et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J Infect. 2022;84(4):566–572. doi: 10.1016/j.jinf.2022.02.003. - DOI - PMC - PubMed
    1. Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi: 10.1038/s41591-021-01292-y. - DOI - PMC - PubMed
    1. Tleyjeh I.M., Saddik B., AlSwaidan N., AlAnazi A., Ramakrishnan R.K., Alhazmi D., et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One. 2021;16(12) doi: 10.1371/journal.pone.0260568. - DOI - PMC - PubMed
    1. Ram-Mohan N., Kim D., Zudock E.J., Hashemi M.M., Tjandra K.C., Rogers A.J., et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin Infect Dis. 2022;74(2):218–226. doi: 10.1093/cid/ciab394. - DOI - PMC - PubMed
    1. Hogan C.A., Stevens B.A., Sahoo M.K., Huang C., Garamani N., Gombar S., et al. High frequency of SARS-CoV-2 RNAemia and association with severe disease. Clin Infect Dis. 2021;72(9):e291–e295. doi: 10.1093/cid/ciaa1054. - DOI - PMC - PubMed